Merger shakeup 2023!

We are all watching two big mergers play out in orthopedics this year.

Nuvasive/Globus

OrthoFix/SeaSpine

Enovis/Lima


Big ortho mergers like this create ripples throughout the industry. There can have a wide range of outcomes, both positive and negative, for the companies, their customers, employees, and shareholders. Historically here are five potential best and worst outcomes when two large orthopedic device companies merge:

Best outcomes:

  1. Increased competitiveness: The merged company may have a larger market share and be better positioned to compete against other players in the orthopedic device market.
  2. Economies of scale: By combining resources and operations, the merged company may be able to reduce costs and improve efficiencies.
  3. Synergies: The combined expertise of both companies may lead to the development of new and innovative products that were not possible before.
  4. Diversification: The merged company may be able to offer a wider range of products and services, making it more attractive to customers.
  5. Improved R&D: The merged company may be able to invest more in research and development, leading to faster innovation and improved products.

Worst outcomes:

  1. Reduced competition: The combined company may gain market share and reduce competition, potentially leading to higher prices and fewer choices for customers.
  2. Job losses: Mergers often result in redundancies and layoffs as the merged company looks to streamline operations and eliminate duplicative roles.
  3. Cultural clashes: The merged company may struggle to integrate different cultures and management styles, leading to conflicts and decreased morale.
  4. Integration challenges: Integrating two large companies with different systems, processes, and procedures can be difficult and time-consuming, potentially leading to delays and disruptions.
  5. Regulatory hurdles: Mergers in the healthcare industry are subject to strict regulatory scrutiny, and the approval process can be lengthy and uncertain, potentially leading to delays and increased costs.

What do you think will be the actual outcomes of Nuvasive/Globus or OrthoFix/SeaSpine ?

email: tiger@tigerbuford.com